ULBI |
ULTRALIFE CORP |
Sep 3, 2024 |
0 |
$0 |
4 |
Sep 3, 2024 |
Director, 10%+ Owner |
NANX |
NANOPHASE TECHNOLOGIES Corp |
Sep 3, 2024 |
0 |
$0 |
4 |
Sep 3, 2024 |
10%+ Owner |
NANX |
NANOPHASE TECHNOLOGIES Corp |
Jun 25, 2024 |
1 |
$0 |
4 |
Jun 26, 2024 |
10%+ Owner |
NANX |
NANOPHASE TECHNOLOGIES Corp |
Mar 1, 2024 |
1 |
$6M |
4 |
Mar 5, 2024 |
10%+ Owner |
NANX |
NANOPHASE TECHNOLOGIES Corp |
Feb 8, 2024 |
4 |
$1.53M |
4 |
Feb 12, 2024 |
10%+ Owner |
CLSD |
Clearside Biomedical, Inc. |
Feb 7, 2024 |
2 |
$600K |
4 |
Feb 9, 2024 |
10%+ Owner |
ULBI |
ULTRALIFE CORP |
Dec 6, 2023 |
2 |
$111K |
4 |
Dec 8, 2023 |
Director, 10%+ Owner |
ULBI |
ULTRALIFE CORP |
Nov 27, 2023 |
3 |
$181K |
4 |
Nov 29, 2023 |
Director, 10%+ Owner |
ULBI |
ULTRALIFE CORP |
Oct 30, 2023 |
3 |
$99K |
4 |
Nov 1, 2023 |
Director, 10%+ Owner |
CLSD |
Clearside Biomedical, Inc. |
Oct 30, 2023 |
3 |
$99.8K |
4 |
Nov 1, 2023 |
10%+ Owner |
CLSD |
Clearside Biomedical, Inc. |
Oct 27, 2023 |
0 |
$0 |
3 |
Nov 1, 2023 |
10%+ Owner |
ULBI |
ULTRALIFE CORP |
Sep 13, 2023 |
3 |
$112K |
4 |
Sep 15, 2023 |
Director, 10%+ Owner |
NANX |
NANOPHASE TECHNOLOGIES Corp |
Aug 21, 2023 |
3 |
$78.9K |
4 |
Aug 23, 2023 |
10%+ Owner |
ULBI |
ULTRALIFE CORP |
Jun 12, 2023 |
3 |
$398K |
4 |
Jun 14, 2023 |
Director, 10%+ Owner |
ULBI |
ULTRALIFE CORP |
Jun 2, 2023 |
1 |
$26.2K |
4 |
Jun 5, 2023 |
Director, 10%+ Owner |
ULBI |
ULTRALIFE CORP |
May 30, 2023 |
3 |
$146K |
4 |
Jun 1, 2023 |
Director, 10%+ Owner |
NANX |
NANOPHASE TECHNOLOGIES Corp |
May 30, 2023 |
3 |
$19.3K |
4 |
Jun 1, 2023 |
10%+ Owner |
NANX |
NANOPHASE TECHNOLOGIES Corp |
May 17, 2023 |
3 |
$56.2K |
4 |
May 19, 2023 |
10%+ Owner |
ULBI |
ULTRALIFE CORP |
May 9, 2023 |
3 |
$117K |
4 |
May 11, 2023 |
Director, 10%+ Owner |
ULBI |
ULTRALIFE CORP |
Mar 9, 2023 |
3 |
$122K |
4 |
Mar 13, 2023 |
Director, 10%+ Owner |
NANX |
NANOPHASE TECHNOLOGIES Corp |
Dec 15, 2022 |
1 |
$331K |
4/A |
Dec 16, 2022 |
10%+ Owner |
ULBI |
ULTRALIFE CORP |
Dec 14, 2022 |
3 |
$152K |
4 |
Dec 16, 2022 |
Director, 10%+ Owner |
ULBI |
ULTRALIFE CORP |
Dec 6, 2022 |
3 |
$279K |
4 |
Dec 8, 2022 |
Director, 10%+ Owner |
NANX |
NANOPHASE TECHNOLOGIES Corp |
Dec 6, 2022 |
3 |
$213K |
4 |
Dec 8, 2022 |
10%+ Owner |
NANX |
NANOPHASE TECHNOLOGIES Corp |
Nov 16, 2022 |
3 |
$185K |
4 |
Nov 18, 2022 |
10%+ Owner |
ULBI |
ULTRALIFE CORP |
Aug 17, 2022 |
2 |
$158K |
4 |
Aug 19, 2022 |
Director, 10%+ Owner |
ULBI |
ULTRALIFE CORP |
Aug 2, 2022 |
3 |
$467K |
4 |
Aug 4, 2022 |
Director, 10%+ Owner |
ULBI |
ULTRALIFE CORP |
Jun 6, 2022 |
2 |
$219K |
4 |
Jun 8, 2022 |
Director, 10%+ Owner |
ULBI |
ULTRALIFE CORP |
Feb 24, 2022 |
3 |
$245K |
4 |
Feb 28, 2022 |
Director, 10%+ Owner |
NANX |
NANOPHASE TECHNOLOGIES Corp |
Dec 21, 2021 |
2 |
$0 |
4 |
Dec 23, 2021 |
10%+ Owner |
ULBI |
ULTRALIFE CORP |
Dec 17, 2021 |
1 |
$297K |
4 |
Dec 20, 2021 |
Director, 10%+ Owner |
CLSD |
Clearside Biomedical, Inc. |
Aug 30, 2021 |
3 |
-$2.92M |
4 |
Sep 1, 2021 |
10%+ Owner |
ULBI |
ULTRALIFE CORP |
Aug 2, 2021 |
3 |
$199K |
4 |
Aug 4, 2021 |
Director, 10%+ Owner |
NANX |
NANOPHASE TECHNOLOGIES Corp |
May 7, 2021 |
2 |
$1.62M |
4 |
May 11, 2021 |
10%+ Owner |